Dr. Michelakos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave RM O217
Chicago, IL 60637Phone+1 773-896-6160
Education & Training
Massachusetts General HospitalResidency, Surgery, 2017 - 2024
University of AthensClass of 2013
Certifications & Licensure
IL State Medical License 2024 - 2026
MA State Medical License 2017 - 2024
Publications & Presentations
PubMed
- Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma.Giulia Cattaneo, Marco Ventin, Shahrzad Arya, Filippos Kontos, Theodoros Michelakos
Cancer Letters. 2024-04-10 - 3 citationsAssociation of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma.Xiaolin Wei, Theodoros Michelakos, Qian He, Xianxing Wang, Yu Chen
The Oncologist. 2023-11-02 - 6 citationsRecurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment.Alessandra Pulvirenti, Ammar A Javed, Theodoros Michelakos, Yurie Sekigami, Jian Zheng
Annals of Surgery. 2023-11-01
Journal Articles
- Hepatocellular Carcinoma in Transplantable Child-Pugh A Cirrhotics: Should Cost Affect Resection vs Transplantation?Theodoros Michelakos, Dimitrios Xourafas, David Berger, James F Markmann, Cristina R Ferrone, Motaz Qadan, Kenneth K Tanabe, Joel T Adler, Nahel Elias, Heidi Yeh, Madh..., Journal of gastrointestinal surgery
Press Mentions
- Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant TherapyJanuary 26th, 2021
Other Languages
- French, Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
